Procept BioRobotics Corp [PRCT] stock is trading at $36.1, up 0.31%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PRCT shares have gain 6.08% over the last week, with a monthly amount glided 18.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on December 12, 2025, when UBS initiated its Buy rating and assigned the stock a price target of $62. Previously, BofA Securities downgraded its rating to Neutral on December 08, 2025, and kept the price target unchanged to $38. On September 02, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $60 on the stock. Stephens started tracking the stock assigning an Overweight rating and suggested a price target of $70 on July 09, 2025. Oppenheimer initiated its recommendation with a Perform. Morgan Stanley started tracking with an Overweight rating for this stock on December 02, 2024, and assigned it a price target of $105. In a note dated November 14, 2024, Jefferies initiated a Hold rating and provided a target price of $95 on this stock.
Procept BioRobotics Corp [PRCT] stock has fluctuated between $27.80 and $92.92 over the past year. Currently, Wall Street analysts expect the stock to reach $54.14 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $36.1 at the most recent close of the market. An investor can expect a potential return of 49.97% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
Procept BioRobotics Corp [NASDAQ:PRCT] reported sales of 299.91M for the trailing twelve months, which represents a growth of 42.76%. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.28%, and Net Profit Margin reading is -0.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.22 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.35 points at the first support level, and at 34.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 36.88, and for the 2nd resistance point, it is at 37.65.
Ratios To Look Out For
For context, Procept BioRobotics Corp’s Current Ratio is 8.43. Further, the Quick Ratio stands at 7.19, while the Cash Ratio is 5.46. Considering the valuation of this stock, the price to sales ratio is 6.73, the price to book ratio is 5.30.
Transactions by insiders
Recent insider trading involved MOLL FREDERIC H, Director, that happened on Aug 13 ’25 when 20000.0 shares were purchased. Director, Desai Antal Rohit completed a deal on Jun 10 ’25 to sell 25000.0 shares. Meanwhile, Director Desai Antal Rohit sold 25000.0 shares on Jun 11 ’25.
